Shares of Neptune Wellness Solutions Inc (NASDAQ:NEPT) (TSE:NTB) have been given a consensus broker rating score of 1.50 (Buy) from the two analysts that cover the stock, Zacks Investment Research reports. One analyst has rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company.
Analysts have set a twelve-month consensus price objective of $6.39 for the company and are expecting that the company will post ($0.03) EPS for the current quarter, according to Zacks. Zacks has also given Neptune Wellness Solutions an industry rank of 76 out of 256 based on the ratings given to related companies.
Several research analysts have recently commented on NEPT shares. Zacks Investment Research raised HAYS PLC/ADR from a “sell” rating to a “hold” rating in a research report on Tuesday, June 18th. BidaskClub lowered Zions Bancorporation NA from a “sell” rating to a “strong sell” rating in a research report on Wednesday, May 15th.
Shares of NEPT traded up $0.14 during trading hours on Monday, hitting $4.96. The company had a trading volume of 1,371,278 shares, compared to its average volume of 802,364. The company has a market cap of $399.33 million, a P/E ratio of -35.43 and a beta of 1.73. Neptune Wellness Solutions has a one year low of $2.42 and a one year high of $5.22. The business’s fifty day moving average price is $4.43.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. CIBC World Markets Inc. acquired a new position in shares of Neptune Wellness Solutions in the first quarter valued at about $63,000. Alpine Group USVI LLC acquired a new position in shares of Neptune Wellness Solutions in the first quarter valued at about $303,000. Two Sigma Advisers LP acquired a new position in shares of Neptune Wellness Solutions in the fourth quarter valued at about $367,000. Finally, Deutsche Bank AG increased its holdings in shares of Neptune Wellness Solutions by 245.9% in the fourth quarter. Deutsche Bank AG now owns 517,135 shares of the biotechnology company’s stock valued at $1,313,000 after purchasing an additional 367,614 shares during the period. 13.97% of the stock is owned by hedge funds and other institutional investors.
Neptune Wellness Solutions Company Profile
Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.
Featured Story: What is total return in investing?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.